Sun Pharma in pink of health after USFDA clears facility post inspection – Business Standard


Moneycontrol.com

Sun Pharma in pink of health after USFDA clears facility post inspection
Business Standard
Sun Pharmaceutical Industries gained 2.4% to Rs 538.40 at 10:00 IST on BSE after the company said that the US drug regulator cleared its Dadra facility based on responses to its inspection conducted in April this year. The announcement was made after ...
Buy, Sell, Hold: 3 stocks being tracked by analysts todayMoneycontrol.com
Sun Pharma gets EIR for Dadra facility; stocks spurt 3.6%Hindu Business Line
Sun Pharma gets USFDA inspection report for Dadra facilityETHealthworld.com

all 8 news articles »